Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L

<b>Background/Objectives:</b> The possibility of progressive liver fibrosis remains even when alanine aminotransferase (ALT) levels are <30 IU/L. Therefore, we aimed to investigate factors that can predict fibrosis progression in patients with metabolic dysfunction-associated steatoti...

全面介紹

Saved in:
書目詳細資料
Main Authors: Miwa Kawanaka, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Ken Nishino, Katsunori Ishii, Takashi Fushimi, Hirofumi Kawamoto, Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima, Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
格式: Article
語言:英语
出版: MDPI AG 2025-06-01
叢編:Diagnostics
主題:
在線閱讀:https://www.mdpi.com/2075-4418/15/13/1591
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍